Esperion Therapeutics
ESPR
#6737
Rank
ยฃ0.38 B
Marketcap
ยฃ1.97
Share price
2.49%
Change (1 day)
107.28%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : ยฃ0.55 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are ยฃ0.55 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ0.51 B9.76%
2022-12-31ยฃ0.47 B10.26%
2021-12-31ยฃ0.42 B30%
2020-12-31ยฃ0.32 B122.28%
2019-12-31ยฃ0.14 B192.66%
2018-12-31ยฃ50.68 M106.66%
2017-12-31ยฃ24.52 M82.17%
2016-12-31ยฃ13.46 M139.98%
2015-12-31ยฃ5.6 M-10.17%
2014-12-31ยฃ6.24 M145.07%
2013-12-31ยฃ2.54 M-83.33%
2012-12-31ยฃ15.28 M188.4%
2011-12-31ยฃ5.29 M
2002-12-31ยฃ7.89 M-3.3%
2001-12-31ยฃ8.16 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ0.94 B 70.27%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.14 B 106.42%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ101.03 B 18,121.23%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ6.46 B 1,065.19%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.48 B-12.75%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.10 B-80.85%๐Ÿ‡บ๐Ÿ‡ธ USA